Drug Safety and Effectiveness in the Real World
A special issue of Pharmacoepidemiology (ISSN 2813-0618).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 9921
Special Issue Editors
2. Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan
3. Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan
Interests: drug safety; drug–drug interaction; effectiveness; real world
Interests: bioinformatics; cancer biomarkeres; pharmacology
Special Issue Information
Dear Colleagues,
Drug safety evaluation is an important issue throughout the lifecycle of drug product development. It is considered an ongoing activity because the premarket testing of drugs cannot detect all potential adverse effects, especially rare events. Therefore, real-world evidence plays an essential role. It is extremely important for clinicians to confirm the effectiveness and safety of treatments and further provide the optimal therapeutic drugs to the patients. Randomized controlled trials are considered to provide the highest level of scientific evidence for clinical therapies. However, drug safety in the real world still presents several challenges. For instance, several specific populations such as children and elderly people are commonly excluded from randomized controlled trials due to ethical issues. Furthermore, drug–drug interactions, inappropriate usage of medications, overdosing and long-term and rare adverse effects are not easily evaluated in traditional clinical trials. Therefore, clinicians must evaluate the benefits and risks and make decisions regarding therapies from various sources, including clinical trials and real-world evidence. In general, using real-world data with appropriate study designs, suitable epidemiological methods and well-controlled bias and confounding effects, real-world evidence can be generated. Such evidence can also bridge the gap from randomized controlled trials to demonstrate the efficacy and safety of medications or medical products in the real world.
Authors are invited to submit original and review articles on drug safety, therapeutic effectiveness and the economic burden of all common therapies which can be published in the Special Issue ‘Drug Safety and Effectiveness in the Real World’ of Pharmacoepidemiology.
I look forward to your valuable contributions.
Dr. Li-Ting Kao
Dr. Yu-Tien Chang
Dr. Ke-Ting Pan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacoepidemiology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug safety
- drug–drug interaction
- effectiveness
- real world
- real-world data
- real-world evidence
- big data
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.